ElectroCore

electroCore, Inc. (Nasdaq: ECOR) is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD.^[1] The current chief executive officer is Daniel S. Goldberger.^[2] electroCore^[3] has one product called gammaCore,^[4][5] a non-invasive, commercially available product that uses vagus nerve stimulation.^[6]

This article is about a medical technology company. For music genres, see Electronicore.

History

The company was co-founded by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD, in 2005.^[1]

In 2018, electroCore, Inc. went public with a $78 million IPO.^[7]

On March 27, 2020, electroCore announced a common stock purchase agreement of up to $25 million with Chicago-based institutional investor Lincoln Park Capital Fund, LLC.^[8]

Products

gammaCore Sapphire CV

In July 2020, the FDA gave an emergency COVID-19 authorization for gammaCore Sapphire CV, a vagus nerve stimulation device, aimed at reducing exacerbations in people potentially affected by the novel coronavirus and have difficulty breathing due to asthma.^[9]

Truvaga

A VNS product owned by Electrocore.^[10]